Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
gynecomastia/умор
Веза се чува у привремену меморију
Страна 1 од 32 резултати
Feminizing Adrenocortical Carcinoma Without Gynecomastia.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Malignant feminizing adrenocortical tumors are exceedingly rare. Their main presentation is gynecomastia. In these estrogen secreting tumors (with or without other adrenocortical hormones) lack of gynecomastia is exceptional as in our case. A 44-year-old man presented with abdominal pain.
Pain, fatigue and depression symptom cluster in survivors of prostate cancer.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Enzalutamide is an androgen receptor inhibitor with a demonstrated overall survival benefit in metastatic castration-resistant prostate cancer. A phase 2 study of enzalutamide monotherapy in patients with hormone-naïve prostate cancer (HNPC) showed a high response rate for the
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
A phase 2 study of enzalutamide monotherapy in patients with hormone naïve prostate cancer demonstrated high prostate specific antigen response rates at 25 weeks, 1 year and 2 years with minimal effects on total body bone mineral density and favorable safety. In this followup analysis we
Antiandrogen monotherapy: indications and results.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Many patients with prostate cancer for whom hormonal therapy is indicated are still physically and sexually active; quality of life is therefore a vital issue when considering treatment options. Traditional castration-based therapies, although effective, have implications with respect to quality of
Bicalutamide-induced hepatotoxicity: A rare adverse effect.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
METHODS
Male, 81 FINAL DIAGNOSIS: Prostate cancer Symptoms: Anorexia • dark urine • joundice • letargy
METHODS
Casodex Clinical Procedure: - Specialty: Oncology.
OBJECTIVE
Adverse events of drug therapy.
BACKGROUND
Bicalutamide is a nonsteroidal anti-androgen used extensively during the initiation
[Anti-thyroid peroxidase in non-neoplastic thyroid pathology].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Anti-thyroid peroxidase antibodies were prospectively assayed and compared with anti-microsome and anti-thyroglobulin antibodies in 203 patients (188 women, 15 men; mean age 42 +/- 14 years). These patients consulted for hyperthyroidism (n = 42, including 18 with Graves' disease), fumary
Use of cyproterone acetate in prostate cancer.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Cyproterone acetate is a progestational antiandrogen with potent antigonadotropic activity that results in rapid suppression of serum testosterone. Used as a single agent, cyproterone acetate yields a total androgen blockade. It may be combined with low-dose diethylstilbestrol, orchiectomy, or LHRH
[Bronchial carcinoma--an overview].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The incidence of lung cancer has exploded in this century. The disease is most commonly diagnosed in the 65-75 year age group but can occur as young as 30 years. Cigarette smoking is usually related to lung cancer in men and the risk of developing lung cancer increases with duration of smoking and
[Primary choriocarcinoma of the bladder: a case report of autopsy].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The patient was a 70-year-old male with complaint of macrohematuria at the first visit to our clinic on June 10, 1986. At that time, cystoscopy revealed a thumb sized papillary tumor and a rice sized non papillary tumor, and the biopsy specimen was pathologically diagnosed as undifferentiated
Atypical onset of bicalutamide-induced liver injury.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Anti-androgen therapy is the leading treatment for advanced prostate cancer and is commonly used for neoadjuvant or adjuvant treatment. Bicalutamide is a non-steroidal anti-androgen, used during the initiation of androgen deprivation therapy along with a luteinizing hormone-releasing hormone agonist
[Klinefelter's syndrome: diagnosis and treatment. Case report].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Klinefelter's syndrome affects 1 in 500 men across all ethnic groups but the diagnosis is often delayed because of substantial variations in clinical presentation. A 26 year-old male came to observation for chronic fatigue. His laboratory data and radiological examination were negative. Examination
Rapid androgen cycling as treatment for patients with prostate cancer.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To investigate the safety and feasibility of rapid androgen cycling for men with progressive prostate cancer.
METHODS
Schedule 1 included a 4-week induction of androgen depletion, followed by 4-week treatment cycles of a monthly gonadotropin-releasing hormone agonist, testosterone on days
Opioid-induced Endocrinopathy
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Opioid-induced endocrinopathy (OIE) is a condition that affects more Americans than other common comorbid conditions such as heart disease and diabetes combined. It is an important and often unrecognized cause of endocrinopathy, and can result in various clinical manifestations such as sexual
[Androgen deprivation therapy in prostate cancer. Indication and systemic consequences].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Androgen deprivation therapy (ADT) is effective in prolonging the progression free survival of patients with symptomatic/metastatic prostate cancer (PC). The reduction of clinical symptoms of tumour disease and the reduction of tumour growth and metastatic dissemination is accompanied by systemic
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
